AdaptHealth (AHCO) vs GeneDx (WGS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
AdaptHealth (AHCO) has outperformed GeneDx (WGS) over the past year, losing 24.9% versus a loss of 69.0%. Over five years, AHCO leads with a -66.7% price change compared with -80.0% for WGS. GeneDx is the larger company by market cap ($1.36 billion vs $983.0 million), about 1.4 times the size.
AdaptHealth converts more of its revenue into profit, with a net margin of -2.2% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AHCO | WGS |
|---|---|---|
| Share price | $7.20 | $45.46 |
| Market cap | $982.98M | $1.36B |
| 1-day change | -0.69% | -7.68% |
| YTD return | -27.71% | -65.05% |
| 1-year return | -24.92% | -68.98% |
| 5-year return | -66.67% | -80.01% |
| Forward P/E | — | 34.93 |
| EPS (TTM) | $-3.23 | $-3.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.24B | $427.54M |
| Revenue growth (YoY) | -0.49% | +39.97% |
| Net income (latest FY) | $-70.79M | $-21.02M |
| Gross margin | 18.77% | 69.74% |
| Operating margin | 2.80% | -3.06% |
| Net margin | -2.18% | -4.92% |
| 52-week high | $13.43 | $170.87 |
| 52-week low | $5.21 | $32.21 |
| Distance from 52-week high | -46.39% | -73.39% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +23.06% | +80.38% |
| Average volume | 2.55M | 869.34K |
| Shares outstanding | 136.53M | 29.97M |
| Employees | 10,900 | 1,300 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AHCO has outperformed WGS by 44.1 percentage points over the past year.
- GeneDx grew revenue faster in its latest fiscal year (+39.97% vs -0.49%).
About AdaptHealth
AHCO stock →AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Health Care · Medical/Nursing Services · 10,900 employees
About GeneDx
WGS stock →GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Health Care · Medical/Nursing Services · 1,300 employees
AHCO vs WGS FAQ
Which is bigger, AdaptHealth or GeneDx?
GeneDx (WGS) is larger, with a market capitalization of $1.36B compared with $982.98M for AdaptHealth (AHCO).
Which stock has performed better over the past year, AHCO or WGS?
AHCO returned -24.92% over the past 12 months, compared with -68.98% for WGS (price return, excluding dividends). Past performance does not predict future results.
Are AdaptHealth and GeneDx in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.